Pancreatic beta cells are responsible for insulin release which is indispensable for normal blood glucose homeostasis. Thankss to an unusual metabolic constellation, the I?-cells act as alimentary detectors by matching their glucose metamorphosis with the insulin secernment, presenting an appropriate measure in the systemic circulation. When metabolized in the I?-cell, glucose promotes the addition of intracellular ATP. This causes the closing of ATP-sensitive K+ channels ( KATP ) which in bend leads to the depolarisation of the plasma membrane doing the gap of voltage-gated Ca2+ channels. The attendant addition in intracellular free Ca2++ both triggers the exocytotic release of the insulin from secretory granules and reinforces the response by exciting the ATP production by the chondriosome. Other KATP independent mechanisms still incompletely understood, including the suppression of AMP-activated protein kinase, potentiate this process1,2.
While type I diabetes is a comparatively well-characterized disease caused by the autoimmune-mediated devastation of the I?-cells, type II diabetes is a less defined status, where defects in glucose detection and a loss of I?-cells combine to cut down insulin secernment, ensuing in deviant blood glucose degrees. A full apprehension of the mechanisms underlying insulin secernment is indispensable to the development of new therapies.
The specific map of the I?-cells requires the activation of several cistrons which are expressed in none or few other tissues. For illustration, the low affinity hexokinase, glucokinase is preferentially expressed in liver and I?-cells. This enzyme facilitates the transition of glucose to glucose-6-phospate and operates as a physiological glucose detector thanks to its alone kinetic belongingss, different to the hexokinases present in other tissues3. More illustrations include other cistrons involved in glucose detection or specific written text factors such as PDX1 or MafA4. The importance of some of those cistrons has been highlighted by the happening of their mutant in a monogenic type of diabetes known as maturity-onset diabetes of the immature ( MODY ) 5 or by the sensing of abnormalcies in insulin secernment in mice bearing decreased activity of these genes6.
Conversely, it has late become apparent that some cistrons functioning a “ housework ” function in most cells and hence expressed in more or less copiousness in most of the other tissues, are absent -or disallowed- in I?-cells7. The two laminitis members of these “ disallowed ” cistrons are monocarboxylate transporter-1 ( MCT-1 ) and lactate dehydrogenase A ( LDHA ) whose look is really low in I?-cells while ubiquitously expressed across other mammalian tissues8,9. All life cells need a uninterrupted production of ATP, usually generated via oxidative phosphorylation-which is oxygen-dependant-in the chondriosome interior membrane. The endurance of the cells under anaerobiotic conditions can happen thanks to anaerobic glycolysis, which involves the decrease of pyruvate to breastfeed thanks to LDHA and the conveyance of pyruvate and lactate across the plasma membrane, which is achieved thanks to a monocarboxylate transporter. Consequently and as an exclusion, glycolysis is entirely aerophilic in I?-cells10 where these two cistron merchandises are absent. Posterior surveies demonstrated that the low look of those cistrons has a dual map: First, guaranting that pyruvate derived from glycolysis is preferentially directed toward mitochondrial oxidation-reinforcing the ability of glucose to excite insulin secernment and, 2nd, to avoid the stimulation of insulin secernment by the pyruvate generated by musculuss during physical exercise11. Indeed, mutants within the SLC16A1 ( MCT-1 ) booster increasing the look of MCT1 were found in two households enduring of exercise-induced hyperinsulinism ( EIHI ) 12. In this autosomal dominant upset, vigorous physical exercising causes inappropriate insulin release, taking to hypoglucemia13. Pullen and colleagues generated a transgenic mouse overexpressing Mct-1 and showed that, in response to exercising, transgene initiation is adequate to forestall the normal suppression of insulin secernment, miming the cardinal characteristics of EIHI and exposing the importance of the absence of this transporter for the normal control of insulin secretion11.
The research lab here suggested as a host and others have late described more than 60 disallowed cistrons in the I?-cell14,15, seven of which are present in both lists. ( you mentioned more than 60, but in the paper less are reference, should I lodge to the Numberss of the reappraisal? ) . These lists include a few good described cistrons, such as hexokinase I, which is “ substituted ” in I?-cells and liver by the much higher Km isoform HK4 ( glucokinase ) as described before. Interestingly, other cistrons cluster into the same functional groups, such as those involved in oxidative emphasis, proliferation or stimulus-secretion yoke and endocytosis ( Cite the paper in readying ) . The importance of the silence of some of these cistrons for the I?-cell is presently being assessed by different members of the host lab.
Whilst there is abundant published and ongoing research focussed to find the map of those I?-cell disallowed cistrons, merely limited information sing the mechanism of silencing is available.
Historically, the extinction of specific cistrons was attributed to the action of specific transcriptional repressers or the absence of specific enhancers16 and the survey of written text webs used to pull all the attending. Nonetheless, in the last old ages, the immense impact that both epigenetic mechanisms ( such as DNA methylation or histone alterations ) and non-coding RNAs have in cistron look has become evident17,18. Therefore, members of the Rutter lab investigated whether DNA methylation or miRNAs contributed to the specific MCT-1 silencing in the I?-cell19. Although they concluded that DNA methylation of Slc16a1 booster does non lend to its silencing, they found that the I?-cell-enriched miRNAs miR-29a/b straight control the look of Mct-1 thought adhering to its 3’UTR.
MiRNAs are a big household -more than a 1000 have been identified so far in humans- of ~22 bases RNAs which regulate virtually every facet of biological science, including development, proliferation, distinction or metamorphosis. It is so non surprising that break of miRNA map contributes to many human diseases, including cardiovascular upsets, malignant neoplastic disease and neurological dysfunctions20.
MicroRNAs are processed from precursor molecules ( pri-miRNAs ) which are usually transcribed by polymerase II21. Thus, look of a big subset of mammalian miRNAs may be transcriptionally linked to the look of other cistrons, leting for coordinate ordinance of miRNA and protein expression22. The pri-miRNA is foremost processed in the karyon by DROSHA and, in mammals, DGCR8 into a ~70nt hairpin, known as pre-miRNA. The pre-miRNA is so exported to the cytol where is further processed by DICER into a little ( ~20 ntds ) RNA semidetached house. In general, one of the strands ( known as the usher ) will be incorporated with an Argonaute protein into a miRNA-induced silencing composite ( miRISC ) while the other one ( rider strand ) is released and degraded23. Most metazoan miRNAs direct RISC to aim messenger RNA by interacting with sites of imperfect complementarity. As a consequence, the miRNA promotes the debasement and/or inhibit the interlingual rendition of the mark messenger RNA, ensuing in repression of its expression24. In general, the most of import part for mark acknowledgment comprises the nucleotides 2-8 of the miRNA-known as the “ seed ” region-and binding sites located in the 3’UTR of the blood relation messenger RNA are more common25.
A function for miRNAs in pancreatic map was foremost pointed out by Poy and coworkers in 2004 who identified an islet-specific miRNA, miR-375, that controls insulin secretion26. Subsequently on, a broader function of miRNAs in pancreas development and, more specifically, I?-cell map was proved by conditional omission of Dicer, a necessary enzyme for miRNA ripening. Therefore, Dicer was indispensable for pancreas development27, maintaining of the grownup pancreas28 and for the development, glucose metamorphosis and an appropriate insulin-secreting map of the mouse pancreatic I?-cells29-31. Over 125 and 200 miRNAs have been detected within the mouse27 and human32 developing pancreas, severally and altered miRNA look profile has been found in different mouse theoretical accounts of type II diabetes33. Nevertheless, the specific map of merely a little subset of these miRNAs has been assessed in I?-cells31,34,35, including miR-29a/b which, as reference before, was proved by the host group and others to play a important function in forbiding the look of Mct-1 in I?-cells19,36.
Therefore the purpose of this undertaking is to unknot the function of miRNAs in pancreatic I?-cell map, concentrating on the function of these non-coding RNAs in the silencing of I?-cell specific disallowed cistrons.
Appraisal of those disallowed cistrons that may be regulated by miRNAs in I?-cells.
Those disallowed cistrons whose look is repressed by miRNAs are expected to be up-regulated as a response of DICER depletion.
Four different systems for DICER depletion will be generated/analysed:
I’-cells islets from Dicer-/- pancreas. Pancreas-specific depletion of Dicer will be achieved by traversing mice transporting conditional smasher allelomorphs of Dicer ( Dicer-flox ) that will be requested to Dr. Clifford J. Tabin37 with mice showing Cre recombinase under the control of the Pdx1 booster ( Pdx1-Cre ) which are available and have been already successfully used to bring forth other void mice in the host lab38,39. ( Should we inquire for the mice before subjecting the grant? )
A mouse insulin-secreting cell line, MIN640 where depletion of Dicer will be achieved by RNAi ( RNA intervention ) , utilizing commercially available siRNAs against Dicer that will be introduced in the cells by transfection.
Mouse I?-cell islets will be isolated and besides transfected with siRNAs against Dicer. Transfection efficiency might be low, in which instance viral vectors available both commercially and in the host lab41, will be used.
Finally, and more significantly, the DICER depletion will be performed -by the same procedures- in the human pancreatic I?-cell line EndoC-I?H1. This cell line has been successfully generated merely a twelvemonth ago by the Scharfmann group42 and is the first human cell line that retains many of the features of primary mature I?-cells, such as the capableness of releasing insulin in response to glucose. It is so an priceless tool for the survey of cistron map in human I?-cells.
In all instances, the effects of DICER depletion in the look of the & gt ; 50 cistrons that have been described as disallowed will be assessed both at the messenger RNA degree ( by contrary written text followed by existent clip PCR, RT-qPCR ) and, when possible, at the protein degree ( by utilizing the most adequate/available method for each protein, such as Western Blotting ( WB ) , Immunostaining or ELISA ) . In add-on, for a ) and vitamin D ) entire RNA from control or Dicer-depleted cells will be sent to the Genomic Laboratory in Hammersmith ( Imperial College nucleus installation ) for High-throughput sequencing ( need to speak to them foremost? ) . By this super-sensitive and accurate method43, we will be able to find the effects of Dicer omission non merely in the look of the disallowed cistrons, but in the whole transcriptome of the pancreatic beta cells.
Those disallowed cistrons whose look is up-regulated as a effect of DICER depletion will be considered as putative miRNA marks, and will be selected for farther probe.
Determination of miRNAs involved in the repression of the selected disallowed cistrons.
The following phase of the undertaking will take to find the specific miRNAs responsible of the silencing of each of the preselected disallowed cistrons and their mechanism of action. Two chief attacks will be undertaken:
In silico surveies
The best characterized characteristics that determine miRNA-target acknowledgment are six-nucleotide seed sites, which absolutely complement the 5 ‘ terminal of the miRNA ( places 2-7 ) 25. Besides, a lucifer with miRNA nucleotide 8, an A across from nucleotide 1 or both augment the seed coupling and implement the miRNA-mediated repression44. These seed-pairing regulations are widely used to foretell functional miRNA target-sites, usually in combination with the secondary construction of the 3’UTR, the neighbouring context information or/and the evolutionary conservation25,45,46. Based on that, in the last old ages several miRNA mark anticipation plans have been published47,48. We will utilize few of these bioinformatics tools, such as TargetScan, Miranda o PicTar47, to foretell miRNA adhering sites present in our campaigner cistrons. These plans typically predict 100s to 1000s of marks for each miRNA, including a high proportion of non bona-fide campaigners, but we will concentrate on those predicted miRNAs that fulfil one of these standards:
Those miRNAs that had been already shown to hold a function in I?-cell map or whose look had been described as altered upon pancreas development and/or carnal theoretical accounts of diabetes.
Those miRNAs that are both abundant and I?-cell particular ( higher look in beta cells in comparing with other tissues ) , since both parametric quantities are thought to impact the capacity of a miRNA to interact with its marks. Members of the host lab have generated a matrix stand foring copiousness versus specificity of several miRNAs expressed in I?-cells, that allows the choice of those miRNAs with highest combination of copiousness and specificity. This attack was successfully used by Pullen and other members of the lab and lead to the find of miR-29b as a represser of Mct-1 in I?-cells19.
Those miRNAs whose look is altered in Ampk-/- mice, available in the host lab as a theoretical account of impaired insulin secernment. Members of this lab found that islets from mice specifically inactivated for the two catalytic alpha fractional monetary units of AMP-activated protein kinase ( Ampk ) 49 which display faulty insulin secernment and glucose homeostasis besides exhibit un-regulation of disallowed cistrons ( personal communicating from Dr GA Rutter-this is n’t published, is it? ) . Those miRNAs downregulated in this theoretical account are hence candidate regulators of disallowed cistrons. We will profile miRNAs in comparing with wild type mice by the usage of taqman-based low denseness arrays, commercially available. This real-time PCR-based system allows the appraisal of the look of 641 mouse-specific miRNAs at the same time by a comparatively low monetary value and has been used successfully before -by myself and others- for miRNA look profiling in multiple and disparate studies32.
In the pattern, these bioinformatics tools have a really good public presentation for anticipation of extremely conserved and consensus binding sites, but a low efficiency for the sensing of non-conserved binding sites every bit good as for those sites with hapless coupling in the seed sequence. Another restriction is that they do n’t take into history the possibility of tissue specific interaction. Therefore, experimental attacks for miRNA mark finding are traveling to be undertaken in analogue:
Ex vivo surveies
An messenger RNA that is being actively repressed by miRNAs is traveling to be found in composites with the quashing miRNA and RISC18. Yoon and co-workers proposed a systematic attack termed MS2-TRAP ( tagged RNA affinity purification ) for placing miRNAs associated with a mark transcript in the cellular context. Briefly, they tagged the mouse linRNA-p21 with MS2 hairpins and co-expressed it in MEFs along with the chimeral protein MS2-GST. Then they affinity-purified the miRNAs nowadays in the RNP composites utilizing glutathione-SH beads and those were detected by qPCR. Out of the 5 miRNA analysed ( predicted to aim linRNA-p21 ) , 4 were enriched in the pulldown and two of them functionally validated 50.
We propose here to utilize the same attack with one or few of the disallowed cistrons that we had selected in 1 ) , executing the experiments in MIN6 and/or EndoC-I?H1 cells. The individuality of the affinity purified miRNAs will be assessed for the miRNAs of involvement ( selected as in 2a ) ) by single RT-qPCR checks and, in a high-throughput mode by taqmann-based arrays or small-RNA ultrasequencing, depending on the measure of cured stuff. This method will let non merely the sensing of miRNAs aiming a given disallowed cistron, but besides proves the direct interaction between the miRNA and the transcript.
The first experiments of this kind-and the optimisation of the technique-will be performed utilizing the Acot7 3’UTR. Acot7 is an acyl-CoA thioesterase involved in acyl-CoA hydrolysis and loosely expressed in mouse tissues, while its degrees are really low in I?-cells14. The disallowance of this cistron is relevant for the right I?-cell map, since ectopic look of this enzyme in ( where? ? ) lead to a lessening in the insulin release in response to glucose ( Figure 1, I need more informations to understand good and explicate this, besides for the figure fable: which sort of concept? which cellsaˆ¦what is the sphere in yellow-required for the consequence? ) aˆ¦
Validation of the miRNA-target messenger RNA interaction.
In order to corroborate that the end point miRNAs are capable of straight aiming the proposed disallowed cistrons, proof experiments will be performed as follows:
The 3’UTR of the disallowed cistron will be cloned downstream of the luciferase ORF ( unfastened reading frame ) in vectors that will be transfected in both MIN6 and EndoC-I?H1 cells, together with inhibitors of the campaigner miRNAs or a control. A higher luciferase activity in cells where the miRNA activity is inhibited will be anticipated. In add-on, punctual mutants of the sequences identified as miRNA adhering sites will be generated in the same newsmans. These mutants should interrupt the miRNA-target interaction, back uping the direct consequence of the miRNA.
Functional proofs will be performed by overexpression/inhibition of the campaigner miRNAs in MIN6 cells, EndoC-I?H1 cells and/or mouse stray islets. The specific attack of transfection will be somewhat different between the several cell types but will fundamentally dwell in: I ) transfection of miRNA look plasmids as in19 or commercially available mimics as in51 and, two ) transfection of commercially available specific LNA ( locked nucleic acid ) miRNA inhibitors. LNA are a category of high-affinity RNA analogues that exhibit a really high specificity and affinity for RNA and DNA, ensuing in a great capacity for suppression of miRNAs ( www.exiqon.com ) .
The effects of these molecules in the disallowed cistrons will be determined at the RNA degree by RT-qPCR. Often, miRNAs exert their map at the degree of interlingual rendition, in which instance changes in the copiousness of the transcripts wo n’t happen. Therefore, alterations at the protein degree will be besides analysed when possible, chiefly by WB, immunoblot or ELISA.
Since degrees of disallowed cistrons are low in I?-cells – the look of those cistrons is already being repressed – it may be, in some instances, hard to observe a farther repression by utilizing miRNA mimics. In those instances, a cell line/model where the mark cistron is extremely express will be selected and used for the miRNA overexpression experiments.
All these sort of proof techniques have been successfully used before by both the host lab and myself19,51, so all the necessary tools will be available and/or comparatively easy generated in the host lab.
Appraisal of the biological relevancy of the studied miRNAs.
Potentially, one miRNA can at the same time quash different marks with disparate maps. In that instance, the phenotype observed after suppressing a given miRNA wo n’t needfully be the same than the one observed when the ( mark ) disallowed cistron is miss-expressed. Then, significantly, when executing the experiments of miRNA overexpression/inhibition ( 3b ) an appraisal of the overall consequence in the I?-cell map will be carried out. This will be possible thanks to the broad spectrum of techniques that have been developed in the host lab during the old ages for the analysis of I?-cell map. Those techniques include in vitro measuring of insulin secernment, electrophysiological measurings and Ca2+ imagining or transmittal negatron microscopy. The choice of any of these techniques or others will be done depending on the miRNA to analyze and the mark cistrons proposed, therefore it is non wholly predictable at this point.
Although the research program exposed would be accomplishable during the continuance of the Junior Research Fellowship, this work would potentially open the door to a whole new degree of survey of the influence of miRNAs in both the normal map of the I?-cell and during the development of disease ( diabetes ) .
For illustration, the specific map of the selected miRNAs could be studied in vivo by bring forthing mice with pancreas-specific miRNA omission or addition of map. It would be particularly interesting to reconstruct the look of specific miRNAs in the ( pancreas-specific ) Dicer-/- mice and to compare the two phenotypes. Both attacks would cast more visible radiation into the miRNA function and, if miRNAs key for the I?-cell map are identified, it could set up the base for the consideration of those miRNAs as curative marks. Several miRNAs have been considered so far for their curative value in different types of disease ( Ref. ) . One of its biggest restrictions is the specific bringing of the mimics or inhibitors to the coveted tissue ; interestingly, one of the unfastened undertakings of the host lab is aimed to bring forth cell-specific bringing agents, which could be of expansive usage in the hereafter in combination with a deeper cognition of the biological science of those little non-coding RNAs in the I?-cell.
( I do n’t retrieve if that was a undertaking, or a coaction, or something elseaˆ¦ )
1 Rutter, G. A. Visualising insulin secernment. The Minkowski Lecture 2004. Diabetologia 47, 1861-1872, doi:10.1007/s00125-004-1541-1 ( 2004 ) .
2 Henquin, J. C. Regulation of insulin secernment: a affair of stage control and amplitude transition. Diabetologia 52, 739-751, doi:10.1007/s00125-009-1314-y ( 2009 ) .
3 Iynedjian, P. B. Molecular physiology of mammalian glucokinase. Cell Mol Life Sci 66, 27-42, doi:10.1007/s00018-008-8322-9 ( 2009 ) .
4 Bernardo, A. S. , Hay, C. W. & A ; Docherty, K. Pancreatic written text factors and their function in the birth, life and endurance of the pancreatic beta cell. Mol Cell Endocrinol 294, 1-9, Department of the Interior: S0303-7207 ( 08 ) 00284-0 [ pii ]
10.1016/j.mce.2008.07.006 ( 2008 ) .
5 Giuffrida, F. M. & A ; Reis, A. F. Genetic and clinical features of maturity-onset diabetes of the immature. Diabetes Obes Metab 7, 318-326, Department of the Interior: DOM399 [ pii ]
10.1111/j.1463-1326.2004.00399.x ( 2005 ) .
6 Rutter, G. A. Nutrient-secretion yoke in the pancreatic islet I?-cell: recent progresss. Mol Aspects Med 22, 247-284, Department of the Interior: S0098299701000139 [ pii ] ( 2001 ) .
7 Quintens, R. , Hendrickx, N. , Lemaire, K. & A ; Schuit, F. Why look of some cistrons is disallowed in I?-cells. Biochem Soc Trans 36, 300-305, Department of the Interior: BST0360300 [ pii ]
10.1042/BST0360300 ( 2008 ) .
8 Zhao, C. , Wilson, M. C. , Schuit, F. , Halestrap, A. P. & A ; Rutter, G. A. Expression and distribution of lactate/monocarboxylate transporter isoforms in pancreatic islets and the exocrine pancreas. Diabetes 50, 361-366 ( 2001 ) .
9 Sekine, N. et al. Low lactate dehydrogenase and high mitochondrial glycerin phosphate dehydrogenase in pancreatic I?-cells. Potential function in alimentary detection. J Biol Chem 269, 4895-4902 ( 1994 ) .
10 Schuit, F. et Al. Metabolic destiny of glucose in purified islet cells. Glucose-regulated anaplerosis in beta cells. J Biol Chem 272, 18572-18579 ( 1997 ) .
11 Pullen, T. J. et Al. Overexpression of monocarboxylate transporter-1 ( SLC16A1 ) in mouse pancreatic I?-cells leads to relative hyperinsulinism during exercising. Diabetes 61, 1719-1725, Department of the Interior: db11-1531 [ pii ]
10.2337/db11-1531 ( 2012 ) .
12 Otonkoski, T. et Al. Physical exercise-induced hypoglycaemia caused by failed silencing of monocarboxylate transporter 1 in pancreatic beta cells. Am J Hum Genet 81, 467-474, doi: S0002-9297 ( 07 ) 61344-5 [ pii ]
10.1086/520960 ( 2007 ) .
13 Otonkoski, T. et Al. Physical exercise-induced hyperinsulinemic hypoglycaemia is an autosomal-dominant trait characterized by unnatural pyruvate-induced insulin release. Diabetes 52, 199-204 ( 2003 ) .
14 Pullen, T. J. et Al. Designation of cistrons selectively disallowed in the pancreatic islet. Islets 2, 89-95, doi:11025 [ pii ]
10.4161/isl.2.2.11025 ( 2010 ) .
15 Thorrez, L. et Al. Tissue-specific disallowance of housekeeping cistrons: the other face of cell distinction. Genome Res 21, 95-105, Department of the Interior: gr.109173.110 [ pii ]
10.1101/gr.109173.110 ( 2011 ) .
16 Gosmain, Y. , Cheyssac, C. , Heddad Masson, M. , Dibner, C. & A ; Philippe, J. Glucagon cistron look in the endocrinal pancreas: the function of the written text factor Pax6 in I±-cell distinction, glucagon biogenesis and secernment. Diabetes Obes Metab 13 Suppl 1, 31-38, doi:10.1111/j.1463-1326.2011.01445.x ( 2011 ) .
17 Jaenisch, R. & A ; Bird, A. Epigenetic ordinance of cistron look: how the genome integrates intrinsic and environmental signals. Nat Genet 33 Suppl, 245-254, Department of the Interior: ng1089 [ pii ]
10.1038/ng1089 ( 2003 ) .
18 Ambros, V. The maps of carnal microRNAs. Nature 431, 350-355, doi:10.1038/nature02871
nature02871 [ pii ] ( 2004 ) .
19 Pullen, T. J. , district attorney Silva Xavier, G. , Kelsey, G. & A ; Rutter, G. A. miR-29a and miR-29b contribute to pancreatic I?-cell-specific silencing of monocarboxylate transporter 1 ( Mct1 ) . Mol Cell Biol 31, 3182-3194, Department of the Interior: MCB.01433-10 [ pii ]
10.1128/MCB.01433-10 ( 2011 ) .
20 Mendell, J. T. & A ; Olson, E. N. MicroRNAs in emphasis signaling and human disease. Cell 148, 1172-1187, Department of the Interior: S0092-8674 ( 12 ) 00162-6 [ pii ]
10.1016/j.cell.2012.02.005 ( 2012 ) .
21 Lee, Y. et Al. MicroRNA cistrons are transcribed by RNA polymerase II. EMBO J 23, 4051-4060, doi:7600385 [ pii ]
10.1038/sj.emboj.7600385 ( 2004 ) .
22 Kim, V. N. , Han, J. & A ; Siomi, M. C. Biogenesis of little RNAs in animate beings. Nat Rev Mol Cell Biol 10, 126-139, Department of the Interior: nrm2632 [ pii ]
10.1038/nrm2632 ( 2009 ) .
23 Yang, J. S. & A ; Lai, E. C. Alternative miRNA biosynthesis tracts and the reading of nucleus miRNA tract mutations. Mol Cell 43, 892-903, Department of the Interior: S1097-2765 ( 11 ) 00588-0 [ pii ]
10.1016/j.molcel.2011.07.024 ( 2011 ) .
24 Fabian, M. R. et Al. miRNA-mediated deadenylation is orchestrated by GW182 through two conserved motives that interact with CCR4-NOT. Nat Struct Mol Biol 18, 1211-1217, doi:10.1038/nsmb.2149
nsmb.2149 [ pii ] ( 2011 ) .
25 Bartel, D. P. MicroRNAs: mark acknowledgment and regulative maps. Cell 136, 215-233, doi: S0092-8674 ( 09 ) 00008-7 [ pii ]
10.1016/j.cell.2009.01.002 ( 2009 ) .
26 Poy, M. N. et Al. A pancreatic islet-specific microRNA regulates insulin secernment. Nature 432, 226-230, Department of the Interior: nature03076 [ pii ]
10.1038/nature03076 ( 2004 ) .
27 Lynn, F. C. et Al. MicroRNA look is required for pancreatic islet cell generation in the mouse. Diabetes 56, 2938-2945, doi: db07-0175 [ pii ]
10.2337/db07-0175 ( 2007 ) .
28 Morita, S. et Al. Dicer is required for keeping grownup pancreas. PLoS One 4, e4212, doi:10.1371/journal.pone.0004212 ( 2009 ) .
29 Kalis, M. et Al. I’-cell specific omission of Dicer1 leads to faulty insulin secernment and diabetes mellitus. PLoS One 6, e29166, Department of the Interior: PONE-D-11-02171 [ pii ]
10.1371/journal.pone.0029166 ( 2011 ) .
30 Mandelbaum, A. D. et Al. Dysregulation of dicer1 in Beta cells impairs islet architecture and glucose metamorphosis. Exp Diabetes Res 2012, 470302, doi:10.1155/2012/470302 ( 2012 ) .
31 Melkman-Zehavi, T. et Al. miRNAs control insulin content in pancreatic I?-cells via downregulation of transcriptional repressers. EMBO J 30, 835-845, Department of the Interior: emboj2010361 [ pii ]
10.1038/emboj.2010.361 ( 2011 ) .
32 Rosero, S. et Al. MicroRNA signature of the human developing pancreas. BMC Genomics 11, 509, doi:1471-2164-11-509 [ pii ]
10.1186/1471-2164-11-509 ( 2010 ) .
33 Dehwah, M. A. , Xu, A. & A ; Huang, Q. MicroRNAs and type 2 diabetes/obesity. J Genet Genomics 39, 11-18, Department of the Interior: S1673-8527 ( 11 ) 00223-2 [ pii ]
10.1016/j.jgg.2011.11.007 ( 2012 ) .
34 Poy, M. N. et Al. miR-375 maintains normal pancreatic alpha- and I?-cell mass. Proc Natl Acad Sci U S A 106, 5813-5818, doi:0810550106 [ pii ]
10.1073/pnas.0810550106 ( 2009 ) .
35 Dumortier, O. & A ; Van Obberghen, E. MicroRNAs in pancreas development. Diabetes Obes Metab 14 Suppl 3, 22-28, doi:10.1111/j.1463-1326.2012.01656.x ( 2012 ) .
36 Roggli, E. et Al. Changes in microRNA look contribute to pancreatic I?-cell disfunction in prediabetic NOD mice. Diabetes 61, 1742-1751, Department of the Interior: db11-1086 [ pii ]
10.2337/db11-1086 ( 2012 ) .
37 Harfe, B. D. , McManus, M. T. , Mansfield, J. H. , Hornstein, E. & A ; Tabin, C. J. The RNaseIII enzyme Dicer is required for morphogenesis but non patterning of the craniate limb. Proc Natl Acad Sci U S A 102, 10898-10903, doi:0504834102 [ pii ]
10.1073/pnas.0504834102 ( 2005 ) .
38 district attorney Silva Xavier, G. et Al. Abnormal glucose tolerance and insulin secernment in pancreas-specific Tcf7l2-null mice. Diabetologia 55, 2667-2676, doi:10.1007/s00125-012-2600-7 ( 2012 ) .
39 Sun, G. et Al. LKB1 omission with the RIP2.Cre transgene modifies pancreatic I?-cell morphology and enhances insulin secernment in vivo. Am J Physiol Endocrinol Metab 298, E1261-1273, Department of the Interior: ajpendo.00100.2010 [ pii ]
10.1152/ajpendo.00100.2010 ( 2010 ) .
40 Miyazaki, J. et Al. Constitution of a pancreatic beta cell line that retains glucose-inducible insulin secernment: particular mention to look of glucose transporter isoforms. Endocrinology 127, 126-132 ( 1990 ) .
41 Meur, G. et Al. Nucleo-cytosolic shuttling of FoxO1 straight regulates mouse Ins2 but non Ins1 cistron look in pancreatic beta cells ( MIN6 ) . J Biol Chem 286, 13647-13656, Department of the Interior: M110.204248 [ pii ]
10.1074/jbc.M110.204248 ( 2011 ) .
42 Ravassard, P. et Al. A genetically engineered human pancreatic I? cell line exhibiting glucose-inducible insulin secernment. J Clin Invest 121, 3589-3597, doi:58447 [ pii ]
10.1172/JCI58447 ( 2011 ) .
43 Malone, J. H. & A ; Oliver, B. Microarrays, deep sequencing and the true step of the transcriptome. BMC Biol 9, 34, doi:1741-7007-9-34 [ pii ]
10.1186/1741-7007-9-34 ( 2011 ) .
44 Grimson, A. et Al. MicroRNA aiming specificity in mammals: determiners beyond seed coupling. Mol Cell 27, 91-105, Department of the Interior: S1097-2765 ( 07 ) 00407-8 [ pii ]
10.1016/j.molcel.2007.06.017 ( 2007 ) .
45 Lewis, B. P. , Burge, C. B. & A ; Bartel, D. P. Conserved seed coupling, frequently flanked by adenosines, indicates that 1000s of human cistrons are microRNA marks. Cell 120, 15-20, Department of the Interior: S0092867404012607 [ pii ]
10.1016/j.cell.2004.12.035 ( 2005 ) .
46 Long, D. et Al. Potent consequence of mark construction on microRNA map. Nat Struct Mol Biol 14, 287-294, Department of the Interior: nsmb1226 [ pii ]
10.1038/nsmb1226 ( 2007 ) .
47 Sethupathy, P. , Megraw, M. & A ; Hatzigeorgiou, A. G. A usher through present computational attacks for the designation of mammalian microRNA marks. Nat Methods 3, 881-886, Department of the Interior: nmeth954 [ pii ]
10.1038/nmeth954 ( 2006 ) .
48 Alexiou, P. , Maragkakis, M. , Papadopoulos, G. L. , Reczko, M. & A ; Hatzigeorgiou, A. G. Lost in interlingual rendition: an appraisal and position for computational microRNA mark designation. Bioinformatics 25, 3049-3055, Department of the Interior: btp565 [ pii ]
10.1093/bioinformatics/btp565 ( 2009 ) .
49 Sun, G. et Al. Ablation of AMP-activated protein kinase alpha1 and alpha2 from mouse pancreatic beta cells and RIP2.Cre nerve cells suppresses insulin release in vivo. Diabetologia 53, 924-936, doi:10.1007/s00125-010-1692-1 ( 2010 ) .
50 Yoon, J. H. , Srikantan, S. & A ; Gorospe, M. MS2-TRAP ( MS2-tagged RNA affinity purification ) : Taging RNA to place associated miRNAs. Methods, Department of the Interior: S1046-2023 ( 12 ) 00159-4 [ pii ]
10.1016/j.ymeth.2012.07.004 ( 2012 ) .
51 Martinez-Sanchez, A. , Dudek, K. A. & A ; Murphy, C. L. Regulation of human chondrocyte map through direct suppression of gristle maestro regulator SOX9 by microRNA-145 ( miRNA-145 ) . J Biol Chem 287, 916-924, Department of the Interior: M111.302430 [ pii ]
10.1074/jbc.M111.302430 ( 2012 ) .